Trial Profile
Clinical trial of A 4250 in patients with non-alcoholic steatohepatitis.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 20 Jan 2017
Price :
$35
*
At a glance
- Drugs Odevixibat (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Adverse reactions; Therapeutic Use
- 10 Feb 2015 New trial record